Literature DB >> 18726081

[A new look at the corticostriatal-thalamocortical circuit in sporadic Parkinson's disease].

H Braak1, K Del Tredici.   

Abstract

The traditional model of corticostriatal-thalamocortical projections, with indirect and direct pathways, provides a simplified and useful explanation for the motor deficits (hypokinesia, bradykinesia) that develop in the course of sporadic Parkinson's disease. In the classic model, major emphasis is placed on the dopamine deficiency in the dorsal striatum that occurs as a result of neuronal loss in the substantia nigra of the midbrain. Nevertheless, because the pathological process that underlies Parkinson's disease also involves many key nondopaminergic connectivities, a revised model is needed that incorporates these projections. The focus on damage to nondopaminergic and extranigral sites is becoming increasingly important for clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726081     DOI: 10.1007/s00115-008-2542-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  29 in total

Review 1.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

2.  Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.

Authors:  Brian H Kopell; Ali R Rezai; Jin Woo Chang; Jerrold L Vitek
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

Review 3.  Circuits and circuit disorders of the basal ganglia.

Authors:  Mahlon R DeLong; Thomas Wichmann
Journal:  Arch Neurol       Date:  2007-01

Review 4.  Basal ganglia and movement disorders: an update.

Authors:  M F Chesselet; J M Delfs
Journal:  Trends Neurosci       Date:  1996-10       Impact factor: 13.837

Review 5.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

6.  Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease.

Authors:  T H McNeill; S A Brown; J A Rafols; I Shoulson
Journal:  Brain Res       Date:  1988-07-05       Impact factor: 3.252

7.  Where does parkinson disease pathology begin in the brain?

Authors:  Kelly Del Tredici; Udo Rüb; Rob A I De Vos; Jürgen R E Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-05       Impact factor: 3.685

8.  Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Authors:  B Stephens; A J Mueller; A F Shering; S H Hood; P Taggart; G W Arbuthnott; J E Bell; L Kilford; A E Kingsbury; S E Daniel; C A Ingham
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 9.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

Review 10.  Basal ganglia macrocircuits.

Authors:  J M Tepper; E D Abercrombie; J P Bolam
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

View more
  2 in total

Review 1.  Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.

Authors:  Josiel Mileno Mack; Marissa Giovanna Schamne; Tuane Bazanella Sampaio; Renata Aparecida Nedel Pértile; Pedro Augusto Carlos Magno Fernandes; Regina P Markus; Rui Daniel Prediger
Journal:  Oxid Med Cell Longev       Date:  2016-10-18       Impact factor: 6.543

2.  Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson's Disease Progression.

Authors:  Selma Yılmazer; Esin Candaş; Gençer Genç; Merve Alaylıoğlu; Büşra Şengül; Ayşegül Gündüz; Hülya Apaydın; Güneş Kızıltan; Sibel Ertan; Erdinç Dursun; Duygu Gezen-Ak
Journal:  Neuromolecular Med       Date:  2020-10-04       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.